Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
Reteplase versus Alteplase for Acute Ischemic Stroke
First author：Shuya Li,Hong-Qiu Gu
Corresponding author：Yongjun Wang
essential_information
- Person in charge：Shuya Li,Hong-Qiu Gu
- Data Sources： OTHERS
- Number of papers：OTHERS20240156
- Published time：2024-06-27
2024-06-27
Published articles
Journal：NEJM
Publication type: Article
IF(IF): 96.2
PMID: 38884332 Link To Pubmed Full text Download
Background And Purpose
Alteplase is the standard agent used in early reperfusion therapy, but alternative thrombolytic agents are needed. The efficacy and safety of reteplase as compared with alteplase in patients with acute ischemic stroke are unclear.
Method
Robust Poisson regression